NCT04270903

Brief Summary

The aim of this study is to assess the signal of melanin using Electron Paramagnetic resonance (EPR). Melanin is a paramagnetic pigment detectable by EPR. Recent advances in instrumentation allows the application of EPR in human beings. The characterization of melanin by EPR could be potentially interesting in the context of melanoma detection and characterization. While another clinical study is currently ongoing aiming at demonstrating the feasibility of the non-invasive detection of the EPR signal of melanin in melanoma patients, it is crucial to have a control group with healthy skin. The aim of the present study is to assess the influence of skin pigmentation of the EPR signal recorded. In the present clinical study, the EPR signal of melanin will be characterized in healthy skin with different phototypes (1-2, 3-4, 5-6) to assess the potential influence of skin pigmentation on the EPR signal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

6 months

First QC Date

February 10, 2020

Last Update Submit

February 12, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of the EPR signal intensity

    Signal height / Double integration / Double integration relative to reference signal

    Through study completion (6 months)

Study Arms (3)

Phototype I - II

EPR measurement at the surface of the skin (arm)

Device: EPR measurement

Phototype III - IV

EPR measurement at the surface of the skin (arm)

Device: EPR measurement

Phototype V - VI

EPR measurement at the surface of the skin (arm)

Device: EPR measurement

Interventions

Subject put in a magnet, magnetic field sweeping around 40 mTesla. Irradiation with a wave with a frequency of 1.1 GHz. A resonator (surface coil) is put at the surface of the skin (arm). The EPR signal is recorded.

Phototype I - IIPhototype III - IVPhototype V - VI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

45 healthy volunteers * 15 subjects with skin Phototype I-II * 15 subjects with Phototype III-IV * 15 subjects with Phototype V-VI

You may qualify if:

  • Healthy volunteers with skin belonging to Phototype I-II, III-IV, V-VI

You may not qualify if:

  • Subjects under 18 years
  • Subjects with pacemakers
  • Subjects with non-removable implants with metal or otherwise not known to be MRI-compatible.
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université catholique de Louvain

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

Pigmentation Disorders

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bernard Gallez, PhD

    Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2020

First Posted

February 17, 2020

Study Start

March 22, 2019

Primary Completion

September 17, 2019

Study Completion

December 20, 2019

Last Updated

February 17, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations